Article

DNA vaccination against Respiratory Syncytial Virus (RSV)

2017-01-01

Abstract excerpt

Despite years of research, a vaccine for RSV is currently not available. One attractive platform for RSV vaccines is DNA vaccination, however to date DNA vaccines have been poorly immunogenic in humans. More understanding of the interplay between route of delivery, expression and immunogenicity of DNA vaccines is required. The aim of this project was to use the novel linear DNA construct developed by Touchlight Ge...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 127c8a0b-609d-5067-bc67-a38636c70c58
DOI: 10.25560/67505

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

DNA vaccination against Respiratory Syncytial Virus (RSV)DOI 10.25560/67505Read

DNA Vaccines Approach: From Concepts to ApplicationsSemantic proximity Read

Guidance for Industry: Considerations for Plasmid DNA Vaccines for Infectious Disease IndicationsSemantic proximity Read

A Brief Review on Dna Vaccines in the Era of COVID-19Semantic proximity Read

DNA vaccines for viral diseasesSemantic proximity Read

DNA VACCINESSemantic proximity Read

DNA vaccines against influenza.Semantic proximity Read

Using Plasmids as DNA Vaccines for Infectious DiseasesSemantic proximity Read

DNA vaccines for targeting bacterial infectionsSemantic proximity Read

Vaccines for COVID-19: perspectives from nucleic acid vaccines to BCG as delivery vector systemSemantic proximity Read

From Plasmids to Protection: A Review of DNA Vaccines Against Infectious DiseasesSemantic proximity Read

Virus-like nanoparticle and DNA vaccination confers protection against respiratory syncytial virus by modulating innate and adaptive immune cells.Semantic proximity Read

DNA vaccines: A safe and efficient platform technology for responding to emerging infectious diseasesSemantic proximity Read